doi:10.1007/s12250-011-3205-x

[1]
Balamurugan Vinayagamurthy, Sen Arnab, Venkatesan Gnanavel, Yadav Vinita, Bhanot Vandna, Bhanuprakash Veerakyathappa, Kumar Singh Raj, 2012: A Rapid and Sensitive One Step-SYBR Green Based Semi Quantitative Real Time RT-PCR for the Detection of peste des petits ruminants Virus in the Clinical Samples, Virologica Sinica, 27, 1-9. doi: 10.1007/s12250-012-3219-z
[2]
Yuxuan Li, Chenxi Zhu, Yi Wang, Heather Miller, Kamel Benlagha, Maria G. Byazrova, Alexander Filatov, Lu Yang, Chaohong Liu, 2026: The role of T cells in influenza infection and vaccination, Virologica Sinica, 41, 10-22. doi: 10.1016/j.virs.2026.02.005
[3]
金宁一, 1997: Research on Gene Structure and Vaccines of HIV, Virologica Sinica, 12, 258-294.
[4]
Ma-ping Deng, Zhi-hong Hu, Hua lin, Deng Wang Fei, 2012: Developments of Subunit and VLP Vaccines Against Influenza A Virus^*, Virologica Sinica, 27, 145-153. doi: 10.1007/s12250-012-3241-1
[5]
Ruikun Du, Qinghua Cui, Lijun Rong, 2021: Flu Universal Vaccines: New Tricks on an Old Virus, Virologica Sinica, 36, 13-24. doi: 10.1007/s12250-020-00283-6
[6]
俞永新, 2004: Progress of Arbo-Flavivirus Chimeric Vaccines, Virologica Sinica, 19, 413-417.
[7]
Benli Huang, Sheng Chen, Zhanxin Wang, Keyu Feng, Yutao Teng, Ruoying Li, Guanming Shao, Jiaqian Rao, Xinheng Zhang, Qingmei Xie, 2025: Development and immunoprotection assessment of novel vaccines for avian infectious bronchitis virus, Virologica Sinica, 40, 462-476. doi: 10.1016/j.virs.2025.03.008
[8]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[9]
Benjamin Silver, Hua Zhu, 2014: Varicella zoster virus vaccines: potential complications and possible improvements, Virologica Sinica, 29, 265-273. doi: 10.1007/s12250-014-3516-9
[10]
Ahmed H. Ghonaim, Sherin R. Rouby, Wedad M. Nageeb, Ashraf Ahmed Elgendy, Rong Xu, Changsheng Jiang, Noha H. Ghonaim, Qigai He, Wentao Li, 2025: Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers, Virologica Sinica, 40, 1-14. doi: 10.1016/j.virs.2024.12.001
[11]
Zhenyuan Wang, Chunjun Qin, Jing Hu, Xiaoqiang Guo, Jian Yin, 2016: Recent advances in synthetic carbohydrate-based human immunodeficiency virus vaccines, Virologica Sinica, 31, 110-117. doi: 10.1007/s12250-015-3691-3
[12]
Li He, Aiping Zang, Min Du, Dapeng Ma, Chuanping Yuan, Chun Zhou, Jing Mu, Huanjing Shi, Dapeng Li, Xulin Huang, Qiang Deng, Jianhua Xiao, Huimin Yan, Lijian Hui, Ke Lan, Sidong Xiong, Xiaoxia Li, Zhong Huang, Hui Xiao, 2015: mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines, Virologica Sinica, 30, 174-189. doi: 10.1007/s12250-015-3606-3
[13]
Xianmiao Ye, Junnan Lu, Zirong Han, Zhishan Fan, Xinru Hu, Lichuang Jiao, Lisha Deng, Wenming Liu, Junqi Liu, Weiqi Pan, Ling Chen, Liqiang Feng, Caijun Sun, 2026: A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses, Virologica Sinica, 41, 423-438. doi: 10.1016/j.virs.2026.04.004
[14]
Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002
[15]
Feixia Gao, Qi Wang, Chenchen Qiu, Jian Luo, Xiuling Li, 2024: Pandemic preparedness of effective vaccines for the outbreak of newly H5N1 highly pathogenic avian influenza virus, Virologica Sinica, 39, 981-985. doi: 10.1016/j.virs.2024.11.005
[16]
Lili Ma, Wei Pan, Miaomiao Yan, Jiali Si, 2025: Bibliometric analysis of global research output on viral vaccines and antivirals in the 21st century, Virologica Sinica, 40, 1061-1065. doi: 10.1016/j.virs.2025.08.002
[17]
孙淑红, 崔治中, 邱玉玉, 2006: Immuno-Suppression of Reticuloendotheliosis Virus Infection on Antibody Responses to Different Vaccines in SPF chickens, Virologica Sinica, 21, 34-37.
[18]
Mohammad Sadraeian, Mohammad Bagher Ghoshoon, Milad Mohkam, Zeinab Karimi, Sara Rasoul-Amini, Younes Ghasemi, 2013: Modification in Media Composition to Obtain Secretory Production of STxB-based Vaccines using Escherichia coli, Virologica Sinica, 28, 43-48. doi: 10.1007/s12250-013-3286-9
[19]
Xia FENG, Shuang-qing YU, Tsugumine Shu, Tetsuro Matano, Mamoru Hasegawa, Xiao-li WANG, Hong-tao MA, Hong-xia LI, Yi ZENG, 2008: Immunogenicity of DNA and Recombinant Sendai Virus Vaccines Expressing the HIV-1 gag Gene, Virologica Sinica, 23, 295-304. doi: 10.1007/s12250-008-2946-y
[20]
Xiangchuan He, Miaomiao Zhang, Chen Zhao, Peiyong Zheng, Xiaoyan Zhang, Jianqing Xu, 2021: From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD), Virologica Sinica, 36, 167-175. doi: 10.1007/s12250-020-00294-3